PREDICTORS OF CLINICALLY SIGNIFICANT PROSTATE CANCER WITH PIRADS CATEGORY 3 MPMRI LESIONS

被引：0
|
作者：
Zorawar, Singh [1 ]
Karen, Huang [1 ]
Derek, Tran [1 ]
Manish, Vira [1 ]
Simon, Hall [1 ]
机构：
[1] Northwell Hlth, New Hyde Pk, NY USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2025年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.urolonc.2024.12.221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
    Ma, Zengni
    Wang, Xinchao
    Zhang, Wanchun
    Gao, Kaisheng
    Wang, Le
    Qian, Lixia
    Mu, Jingjun
    Zheng, Zhongyi
    Cao, Xiaoming
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [22] The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
    Xin Zhang
    Hua Hong
    Danyan Liang
    Cancer Imaging, 22
  • [23] PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview
    Caracciolo, Matteo
    Castello, Angelo
    Lopci, Egesta
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 30 - 38
  • [24] Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
    Zengni Ma
    Xinchao Wang
    Wanchun Zhang
    Kaisheng Gao
    Le Wang
    Lixia Qian
    Jingjun Mu
    Zhongyi Zheng
    Xiaoming Cao
    World Journal of Surgical Oncology, 21
  • [25] The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
    Zhang, Xin
    Hong, Hua
    Liang, Danyan
    CANCER IMAGING, 2022, 22 (01)
  • [26] The stanford prostate cancer calculator: Development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer
    Wang, Nancy N.
    Zhou, Steve R.
    Chen, Leo
    Tibshirani, Robert
    Fan, Richard E.
    Ghanouni, Pejman
    Thong, Alan E.
    To'o, Katherine J.
    Ghabili, Kamyar
    Nix, Jeffrey W.
    Gordetsky, Jennifer B.
    Sprenkle, Preston
    Rais-Bahrami, Soroush
    Sonn, Geoffrey A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 831.e19 - 831.e27
  • [27] THE ASSOCIATION BETWEEN PSA DENSITY AND THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PIRADS SCORES IN MEN WITH POSITIVE MPMRI. WHEN PSA DENSITY CAN HELP AVOIDING PROSTATE BIOPSY?
    Pellegrino, Francesco
    Gandaglia, Giorgio
    Stabile, Armando
    Cucchiara, Vito
    Bandini, Marco
    Mazzone, Elio
    Rosiello, Giuseppe
    Sorce, Gabriele
    Pellegrino, Antony
    Longoni, Mattia
    Scilipoti, Pietro
    Quarta, Leonardo
    Zaurito, Paolo
    Fossati, Nicola
    Zaffuto, Emanuele
    Deho, Federico
    De Cobelli, Francesco
    Brembilla, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E1049 - E1049
  • [28] Re: Risk of Clinically Significant Prostate Cancer Associated with Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI Editorial Comment
    Siegel, Cary
    JOURNAL OF UROLOGY, 2018, 200 (01): : 11 - 11
  • [29] PIRADS 3 LESIONS CHARACTERISED BY MP-MRI OF THE PROSTATE CORRESPOND WITH AN INTERMEDIATE TO HIGH RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER ON WHOLE SPECIMEN HISTOPATHOLOGY-A RETROSPECTIVE REVIEW OF 42 CASES
    Scott, Susan E.
    Gianduzzo, Troy
    Coughlin, Geoff
    Kua, Boon
    Parkinson, Rob
    Samaratunga, Hemamali
    Yaxley, John
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 59 - 59
  • [30] Predicting clinically significant prostate cancer following mpMRI - analyses from a high-volume center
    Jahnen, M.
    Hausler, T.
    Ankerst, D. P.
    Meissner, V. H.
    Gschwend, J. E.
    Herkommer, K.
    EUROPEAN UROLOGY, 2024, 85 : S1094 - S1095
12345